Ferretti Bębenek supported Clinscience in the purchase of a majority stake in the Italian group Exom

The Italian group Exom, dealing with the design, supervision, monitoring and management of clinical trials, recently signed an agreement to sell a majority stake to Clinscience, which aims to help in the development and conduct of clinical trials using innovative solutions. Ferretti Bębenek has had the great pleasure of supporting Clinscience throughout the entire process.

Clinscience’s Acquisition Of 60% Interest In The DigitalCRO—EXOM Group